For: | Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: The role of tumor invading T cells. World J Gastroenterol 2006; 12(45): 7233-7238 [PMID: 17143936 DOI: 10.3748/wjg.v12.i45.7233] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i45/7233.htm |
Number | Citing Articles |
1 |
Gabriela Schiechl, Bernhard Bauer, Ivan Fuss, Sven A. Lang, Christian Moser, Petra Ruemmele, Stefan Rose-John, Markus F. Neurath, Edward K. Geissler, Hans-Jürgen Schlitt, Warren Strober, Stefan Fichtner-Feigl. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11bhighGr1low macrophages. Journal of Clinical Investigation 2011; 121(5): 1692 doi: 10.1172/JCI42540
|
2 |
Christina Eich, Johannes F. Vogt, Vivian Längst, Björn E. Clausen, Nadine Hövelmeyer. Isolation and high-dimensional flow cytometric analysis of tumor-infiltrating leukocytes in a mouse model of colorectal cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1295863
|
3 |
Amritha Venkatesh, Harika Nandigam, Maria Muccioli, Manindra Singh, Tiffany Loftus, Deana Lewis, Michelle Pate, Fabian Benencia. Regulation of inflammatory factors by double-stranded RNA receptors in breast cancer cells. Immunobiology 2018; 223(6-7): 466 doi: 10.1016/j.imbio.2017.11.005
|
4 |
Mehdi Dehghani, Shokouh Sharifpour, Zahra Amirghofran, Hamid Reza Zare. Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin’s lymphoma patients. Medical Oncology 2012; 29(4): 2364 doi: 10.1007/s12032-012-0176-1
|
5 |
Emilien Loeuillard, Caitlin B. Conboy, Gregory J. Gores, Sumera I. Ilyas. Immunobiology of cholangiocarcinoma. JHEP Reports 2019; 1(4): 297 doi: 10.1016/j.jhepr.2019.06.003
|
6 |
Xueran Guo, Chengwei He, Shuzi Xin, Han Gao, Boya Wang, Xiaohui Liu, Sitian Zhang, Fengrong Gong, Xinyi Yu, Luming Pan, Fangling Sun, Jingdong Xu. Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut. Immunity, Inflammation and Disease 2023; 11(9) doi: 10.1002/iid3.1005
|
7 |
Yingxiang Chen, Cui Zhang, Xiang Zou, Miao Yu, Bo Yang, Chen-Feng Ji, Shi-Yong Gao, Jun Li, Bin Liu. Identification of macrophage related gene in colorectal cancer patients and their functional roles. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-01010-0
|
8 |
Wei Luo, Wang-Jun Liao, Yong-Ta Huang, Min Shi, Yuan Zhang, Qian Wen, Ming-Qian Zhou, Li Ma. Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation. Cellular Immunology 2011; 270(1): 47 doi: 10.1016/j.cellimm.2011.03.024
|
9 |
Mei Guo, Jun Dou. Advances and perspectives of colorectal cancer stem cell vaccine. Biomedicine & Pharmacotherapy 2015; 76: 107 doi: 10.1016/j.biopha.2015.10.027
|
10 |
B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, F Klauschen, K Joehrens, A Warth, M Renner, A Mehrabi, M Hafezi, A Thelen, P Schirmacher, W Weichert. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. British Journal of Cancer 2013; 109(10): 2665 doi: 10.1038/bjc.2013.610
|
11 |
Monica Benvenuto, Pierpaolo Sileri, Piero Rossi, Laura Masuelli, Massimo Fantini, Monica Nanni, Luana Franceschilli, Giuseppe Sconocchia, Giulia Lanzilli, Roberto Arriga, Giovanni Faggioni, Florigio Lista, Augusto Orlandi, Vittorio Manzari, Achille Lucio Gaspari, Andrea Modesti, Roberto Bei. Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0455-7
|
12 |
Yavuz Ozdemir, Mehmet Levhi Akin, Ilker Sucullu, Ahmet Ziya Balta, Ergun Yucel. Pretreatment Neutrophil/Lymphocyte Ratio as a Prognostic Aid in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 2014; 15(6): 2647 doi: 10.7314/APJCP.2014.15.6.2647
|
13 |
Yaxiao Lu, Jingwei Yu, Wenchen Gong, Liping Su, Xiuhua Sun, Ou Bai, Hui Zhou, Xue Guan, Tingting Zhang, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Bin Meng, Xiubao Ren, Xianhuo Wang, Huilai Zhang. An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.708784
|
14 |
Stephanie C. Casey, Amedeo Amedei, Katia Aquilano, Asfar S. Azmi, Fabian Benencia, Dipita Bhakta, Alan E. Bilsland, Chandra S. Boosani, Sophie Chen, Maria Rosa Ciriolo, Sarah Crawford, Hiromasa Fujii, Alexandros G. Georgakilas, Gunjan Guha, Dorota Halicka, William G. Helferich, Petr Heneberg, Kanya Honoki, W. Nicol Keith, Sid P. Kerkar, Sulma I. Mohammed, Elena Niccolai, Somaira Nowsheen, H.P. Vasantha Rupasinghe, Abbas Samadi, Neetu Singh, Wamidh H. Talib, Vasundara Venkateswaran, Richard L. Whelan, Xujuan Yang, Dean W. Felsher. Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology 2015; 35: S199 doi: 10.1016/j.semcancer.2015.02.007
|
15 |
T P W McMullen, R Lai, L Dabbagh, T M Wallace, C J De Gara. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules. Clinical and Experimental Immunology 2010; 161(1): 81 doi: 10.1111/j.1365-2249.2010.04147.x
|
16 |
Taxiarchis Konstantinos Nikolouzakis, Emmanuel Chrysos, Anca Oana Docea, Persefoni Fragkiadaki, John Souglakos, John Tsiaoussis, Aristidis Tsatsakis. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy. Cancers 2024; 16(11): 1995 doi: 10.3390/cancers16111995
|
17 |
Dan Cao, Na Xu, Yuan Chen, Hongyan Zhang, Yuting Li, Zheming Yuan. Construction of a Pearson- and MIC-Based Co-expression Network to Identify Potential Cancer Genes. Interdisciplinary Sciences: Computational Life Sciences 2022; 14(1): 245 doi: 10.1007/s12539-021-00485-w
|
18 |
Eda ERDİŞ, Birsen YÜCEL. Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Tumors. ENT Updates 2020; doi: 10.32448/entupdates.696940
|
19 |
Lichao Cao, Fang Chen, Long Xu, Jian Zeng, Yun Wang, Shenrui Zhang, Ying Ba, Hezi Zhang. Prognostic cellular senescence-related lncRNAs patterns to predict clinical outcome and immune response in colon cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1450135
|
20 |
Yong-Hong Huang, Yun-Fei Cao, Zhi-Yuan Jiang, Sen Zhang, Feng Gao. Th22 cell accumulation is associated with colorectal cancer development. World Journal of Gastroenterology 2015; 21(14): 4216-4224 doi: 10.3748/wjg.v21.i14.4216
|
21 |
Zhu Zeng, Xiaofeng Xu, Dan Chen. Dendritic Cells: Biophysics, Tumor Microenvironment and Chinese Traditional Medicine. SpringerBriefs in Biochemistry and Molecular Biology 2015; : 55 doi: 10.1007/978-94-017-7405-5_5
|
22 |
Imke Atreya, Markus F Neurath. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Review of Anticancer Therapy 2008; 8(4): 561 doi: 10.1586/14737140.8.4.561
|
23 |
Qingbin Wu, Tao Hu, Erliang Zheng, Xiangbing Deng, Ziqiang Wang. Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer. Medicine 2017; 96(22): e7051 doi: 10.1097/MD.0000000000007051
|
24 |
Sum-Fu Chiang, Hsin-Yuan Hung, Reiping Tang, Chung Rong Changchien, Jinn-Shiun Chen, Yau-Tong You, Jy-Ming Chiang, Jr-Rung Lin. Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?. International Journal of Colorectal Disease 2012; 27(10): 1347 doi: 10.1007/s00384-012-1459-x
|
25 |
Markus F. Neurath, Susetta Finotto. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine & Growth Factor Reviews 2011; 22(2): 83 doi: 10.1016/j.cytogfr.2011.02.003
|
26 |
Mu-Xing Li, Xue-Min Liu, Xu-Feng Zhang, Jian-Fei Zhang, Wan-Li Wang, Ying Zhu, Jian Dong, Ji-Wen Cheng, Zheng-Wen Liu, Le Ma, Yi Lv. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. International Journal of Cancer 2014; 134(10): 2403 doi: 10.1002/ijc.28536
|
27 |
Paola Pisani. Commentary: How obesity and physical activity contribute to colorectal cancer. Colorectal Disease 2009; 11(7): 701 doi: 10.1111/j.1463-1318.2009.02001.x
|
28 |
L Ferdinande, C Decaestecker, L Verset, A Mathieu, X Moles Lopez, A-M Negulescu, T Van Maerken, I Salmon, C A Cuvelier, P Demetter. Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. British Journal of Cancer 2012; 106(1): 141 doi: 10.1038/bjc.2011.513
|
29 |
Amit Merchea, Zaid M. Abdelsattar, Timucin Taner, Patrick G. Dean, Dorin T. Colibaseanu, David W. Larson, Eric J. Dozois. Outcomes of Colorectal Cancer Arising in Solid Organ Transplant Recipients. Journal of Gastrointestinal Surgery 2014; 18(3): 599 doi: 10.1007/s11605-013-2402-3
|
30 |
G O'Callaghan, J Kelly, F Shanahan, A Houston. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. British Journal of Cancer 2008; 99(3): 502 doi: 10.1038/sj.bjc.6604490
|
31 |
Xiaochen Xu, Xinwen Zhang, Ruilong Kou, Yihao Liu, Siqi Chen, Zuguo Li, Zhiyuan Jian, Zhenran wang. Prognosis and immunotherapy response prediction based on M2 macrophage-related genes in colon cancer. Journal of Cancer Research and Clinical Oncology 2024; 150(2) doi: 10.1007/s00432-023-05573-6
|
32 |
S Danese, A Mantovani. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer. Oncogene 2010; 29(23): 3313 doi: 10.1038/onc.2010.109
|
33 |
Gabriele Sales, Enrica Calura, Paolo Martini, Chiara Romualdi. Graphite Web: web tool for gene set analysis exploiting pathway topology. Nucleic Acids Research 2013; 41(W1): W89 doi: 10.1093/nar/gkt386
|
34 |
XUE LU, CHUN LI, YONG-KUN WANG, KUN JIANG, XIAO-DONG GAI. Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction. Oncology Letters 2014; 7(6): 1992 doi: 10.3892/ol.2014.1994
|
35 |
Kristen M. Drescher, Poonam Sharma, Henry T. Lynch, C. Pauza. Current Hypotheses on How Microsatellite Instability Leads to Enhanced Survival of Lynch Syndrome Patients. Journal of Immunology Research 2010; 2010(1) doi: 10.1155/2010/170432
|
36 |
Feyzullah Uçmak, Elif Tuğba Tuncel. Relationship Between Lesions in Adenomatous Polyp-Dysplasia-Colorectal Cancer Sequence and Neutrophil-to-Lymphocyte Ratio. Medical Science Monitor 2016; 22: 4536 doi: 10.12659/MSM.898879
|
37 |
Vijay G. Peddareddigari, Dingzhi Wang, Raymond N. DuBois. The Tumor Microenvironment in Colorectal Carcinogenesis. Cancer Microenvironment 2010; 3(1): 149 doi: 10.1007/s12307-010-0038-3
|
38 |
Qing-Bin Wu, Meng Wang, Tao Hu, Wan-Bin He, Zi-Qiang Wang. Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer. Medicine 2016; 95(44): e4945 doi: 10.1097/MD.0000000000004945
|
39 |
Atsuko Kasajima, Christine Sers, Hironobu Sasano, Korinna Jöhrens, Albrecht Stenzinger, Aurelia Noske, Ann-Christin Buckendahl, Silvia Darb-Esfahani, Berit Maria Müller, Jan Budczies, Annika Lehman, Manfred Dietel, Carsten Denkert, Wilko Weichert. Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Human Pathology 2010; 41(12): 1758 doi: 10.1016/j.humpath.2010.05.014
|
40 |
James C. Fleet. Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 307(3): G249 doi: 10.1152/ajpgi.00019.2014
|
41 |
Juan Li, Yanna Cheng, Xinke Zhang, Lei Zheng, Zhen Han, Pingli Li, Yuliang Xiao, Qian Zhang, Fengshan Wang. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1–thymopentin fusion peptide and its binding to TLR2. Cancer Letters 2013; 337(2): 237 doi: 10.1016/j.canlet.2013.05.006
|
42 |
Kathleen Ebelt, Gregor Babaryka, Bernhard Frankenberger, Christian G. Stief, Wolfgang Eisenmenger, Thomas Kirchner, Dolores J. Schendel, Elfriede Noessner. Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters. European Journal of Cancer 2009; 45(9): 1664 doi: 10.1016/j.ejca.2009.02.015
|
43 |
Qi Liu, Li Liao. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis. Autoimmunity 2024; 57(1) doi: 10.1080/08916934.2024.2321908
|
44 |
Yan-Jie Xu, Jie-Min Zhao, Cao Gao, Xue-Feng Ni, Wei Wang, Wen-Wei Hu, Chang-Ping Wu. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway. Cellular Signalling 2021; 86: 110095 doi: 10.1016/j.cellsig.2021.110095
|
45 |
Maximilian J. Waldner, Stefan Wirtz, Christoph Becker, Daniel Seidel, Ingrid Tubbe, Kyra Cappel, Patricia S. Hähnel, Peter R. Galle, Martin Schuler, Markus F. Neurath. Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer. Inflammatory Bowel Diseases 2010; 16(4): 559 doi: 10.1002/ibd.21107
|
46 |
Hao Cheng, Feiwu Long, Mukesh Jaiswar, Lie Yang, Cun Wang, Zongguang Zhou. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis. Scientific Reports 2015; 5(1) doi: 10.1038/srep11026
|
47 |
Andrea Nicolini, Angelo Carpi. Immune manipulation of advanced breast cancer: An interpretative model of the relationship between immune system and tumor cell biology. Medicinal Research Reviews 2009; 29(3): 436 doi: 10.1002/med.20143
|
48 |
Claudia Papewalis, Benedikt Jacobs, Anna M. Baran, Margret Ehlers, Nikolas H. Stoecklein, Holger S. Willenberg, Sven Schinner, Martin Anlauf, Andreas Raffel, Kenko Cupisti, Roland Fenk, Werner A. Scherbaum, Matthias Schott. Increased numbers of tumor-lysing monocytes in cancer patients. Molecular and Cellular Endocrinology 2011; 337(1-2): 52 doi: 10.1016/j.mce.2011.01.020
|
49 |
Maria Muccioli, Caitlin Longstaff, Fabian Benencia. Absence of CD4 T-Cell Help Provides a Robust CD8 T-Cell Response While Inducing Effective Memory in a Preclinical Model of Melanoma. Immunotherapy 2012; 4(5): 477 doi: 10.2217/imt.12.39
|
50 |
Boya Zhong, Guangyu Ma, Ayako Sato, Osamu Shimozato, Hongdan Liu, Quanhai Li, Masato Shingyoji, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima, Masatoshi Tagawa. Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen. Journal of Immunology Research 2015; 2015: 1 doi: 10.1155/2015/743828
|
51 |
Fabian Benencia, Leslee Sprague, John McGinty, Michelle Pate, Maria Muccioli. Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination. Journal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/425476
|
52 |
Takashi Ueno, Takahiro Tsuchikawa, Kanako C. Hatanaka, Yutaka Hatanaka, Tomoko Mitsuhashi, Yoshitsugu Nakanishi, Takehiro Noji, Toru Nakamura, Keisuke Okamura, Yoshihiro Matsuno, Satoshi Hirano. Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma. Oncotarget 2018; 9(28): 20034 doi: 10.18632/oncotarget.25050
|
53 |
Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, Awal Ayaz Khan, Galal Yahya, Simona Cavalu. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. Journal of Clinical Medicine 2023; 12(9): 3127 doi: 10.3390/jcm12093127
|
54 |
Kristine Moltu, Karen Henjum, Nikolaus G. Oberprieler, Bjørn A. Bjørnbeth, Kjetil Taskén. Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E2. Human Immunology 2017; 78(2): 129 doi: 10.1016/j.humimm.2016.10.007
|
55 |
Lurmag Orta, David S. Klimstra, Jing Qin, Patricia Mecca, Laura H. Tang, Klaus J. Busam, Jinru Shia. Towards Identification of Hereditary DNA Mismatch Repair Deficiency: Sebaceous Neoplasm Warrants Routine Immunohistochemical Screening Regardless of Patient's Age or Other Clinical Characteristics. American Journal of Surgical Pathology 2009; 33(6): 934 doi: 10.1097/PAS.0b013e318199edca
|
56 |
Sun-Young Lee, Katsuya Miyai, Hye Seung Han, Dae-Yong Hwang, Moo Kyung Seong, Heekyung Chung, Barbara H. Jung, Bikash Devaraj, Kathleen L. McGuire, John M. Carethers. Microsatellite Instability, EMAST, and Morphology Associations with T Cell Infiltration in Colorectal Neoplasia. Digestive Diseases and Sciences 2012; 57(1): 72 doi: 10.1007/s10620-011-1825-5
|
57 |
Delphine Uwamariya, Déogratias Ruhangaza, Belson Rugwizangoga, Antonio Giovanni Solimando. Pathological Characteristics, Prognostic Determinants and the Outcome of Patients Diagnosed with Colorectal Adenocarcinoma at the University Teaching Hospital of Kigali. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/6608870
|
58 |
Meeta P Pradhan, Kshithija Nagulapalli, Mathew J Palakal. Cliques for the identification of gene signatures for colorectal cancer across population. BMC Systems Biology 2012; 6(S3) doi: 10.1186/1752-0509-6-S3-S17
|
59 |
Wei Luo, Wang‐Jun Liao, Yong‐Ta Huang, Min Shi, Yuan Zhang, Qian Wen, Ming‐Qian Zhou, Li Ma. Normalization of T cell receptor repertoire diversity in patients with advanced colorectal cancer who responded to chemotherapy. Cancer Science 2011; 102(4): 706 doi: 10.1111/j.1349-7006.2011.01868.x
|
60 |
Tham H. Hoang, Yue Zhao, Yiu Lam, Stephanie Piekos, Yueh-Chiang Han, Cameron Reilly, Pujan Joshi, Seung-Hyun Hong, Chang Ohk Sung, Charles Giardina, Dong-Guk Shin. BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45304-x
|
61 |
Robert Thimme, Michaela Neagu, Tobias Boettler, Christoph Neumann-Haefelin, Nadine Kersting, Michael Geissler, Frank Makowiec, Robert Obermaier, Ulrich T. Hopt, Hubert E. Blum, Hans Christian Spangenberg. Comprehensive analysis of the α-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Hepatology 2008; 48(6): 1821 doi: 10.1002/hep.22535
|